COVID-19: How Nuclear Medicine Can Provide A Differential Diagnosis In A Very Dubious Case

Author(s): Maria Silvia De Feo, Viviana Frantellizzi*, Giuseppe De Vincentis

Journal Name: Coronaviruses
The World's First International Journal Dedicated to Coronaviruses

Volume 2 , Issue 7 , 2021

Article ID: e230621188924
Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Background: We present the case of a 55-year-old woman, admitted to the Infectious Disease Department of Policlinico Umberto I, Rome, in mid-March 2020, with suspicion of COVID-19 infection.

Objective: The rRT-PCR was negative, and the following CT scan, performed to exclude false-negative results and help diagnosis, was inconclusive.

Methods: It was decided to submit the patient to a 99mTc-HMPAO-labelled leukocyte scan.

Results: This exam led to the diagnosis of infective endocarditis.

Conclusion: In the present pandemic scenario, 99mTc-HMPAO-labelled leukocyte scan represents a reliable imaging technique for differential diagnosis with COVID-19 in patients with confusing clinical signs, possible false-negative rRT-PCR results, and inconclusive CT scan.

Keywords: COVID-19, SARS-CoV-2, 99mTc-HMPAO-labelled leukocyte, differential diagnosis, FUO, CT scan.

open access plus

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2021
Published on: 09 December, 2020
Article ID: e230621188924
Pages: 3
DOI: 10.2174/2666796701999201209142919

Article Metrics

PDF: 13